Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suzhou Minor Pharmaceutical Technology

Request full access

Small molecule drug integrated research and development services

Suzhou Shi, ChinaFounded 2008

About Suzhou Minor Pharmaceutical Technology

Suzhou Minor Pharmaceutical Technology Co., Ltd. (Medinoah) is a contract development and manufacturing organization (CDMO) focused on small molecule chemical drugs. Founded in December 2008 by Dr. Yanong Daniel Wang, the company is headquartered in the BioBay of Suzhou Industrial Park, China. Dr. Wang holds a Ph.D. in Organic Chemistry from the University of Delaware and previously served as a principal scientist at Wyeth in the United States, where he gained extensive experience in new drug development and R&D management.

Medinoah provides an integrated, end-to-end service chain for both innovative and generic drugs, catering to the needs of domestic and international pharmaceutical enterprises at various stages of drug research. The company's core business encompasses Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO), and Chemistry, Manufacturing, and Controls (CMC) services. Its offerings include preclinical chemical research, custom synthesis of high-end products, process chemistry, and the production of Active Pharmaceutical Ingredients (APIs) and intermediates. The firm also specializes in complex chemistries such as chiral compounds and antibody-drug conjugates (ADCs).

The company operates a business model that provides full-chain services from early-stage research and process optimization to pilot-scale and GMP-compliant production for commercialization. Medinoah has established a research and development center in Hefei and a GMP-certified manufacturing plant in Zouping, Shandong, enabling it to offer one-stop-shop services to its clients. The company has received multiple rounds of funding, with its most recent B-round financing completed in February 2024.

Source: Dealroom company data

At a glance

Status
Operational
Employees
12
Open positions
1
Dealroom signal
19.3/100

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Mar 2023 $14M $55M Addor Capital · Oriza Holdings · National Small and Medium Enterprise Development ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Suzhou Minor Pharmaceutical Technology website traffic

Latest recorded traffic for Suzhou Minor Pharmaceutical Technology is 150 monthly website visits, up 0% over the last three months. Suzhou Minor Pharmaceutical Technology's team grew 0% over the past year.

Latest monthly visits150 3-month web change0% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Suzhou Minor Pharmaceutical Technology in the Suzhou Shi ecosystem

Live from Dealroom

The Suzhou Minor Pharmaceutical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Addor Capital
  • Oriza Holdings
  • National Small and Medium Enterprise Development
Employees 12 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suzhou Minor Pharmaceutical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Minor Pharmaceutical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.